| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |